Advanced Cardiovascular Life Support Exam A Answers

Advanced Cardiovascular Life Support (ACLS) Exam A Answers: A Comprehensive Study Guide

Preparing for the Advanced Cardiovascular Life Support (ACLS) certification can feel overwhelming, especially when you are faced with the specific format of Exam A. This guide breaks down the essential concepts, provides sample questions with detailed answers, and offers practical study strategies to help you master the material and walk into the testing center with confidence. By focusing on the core algorithms, pharmacology, and team dynamics that ACLS emphasizes, you will be able to interpret the exam’s scenarios correctly and select the best responses every time.

Understanding the ACLS Exam A Format

Exam A is one of the two written tests used by the American Heart Association (AHA) to evaluate a provider’s knowledge before the hands‑on skills session. It consists of 50 multiple‑choice questions that cover the full ACLS curriculum, including cardiac arrest management, acute coronary syndromes, stroke, and post‑resuscitation care. Each question presents a clinical vignette followed by four answer options; only one is correct. The test is timed, but most candidates find that a solid grasp of the underlying principles allows them to answer within the allotted period.

Key Areas Tested

• Basic Life Support (BLS) foundations – chest compression depth, rate, and recoil; airway management basics.
• ACLS algorithms – Cardiac Arrest (VF/pVT, PEA/asystole), Bradycardia, Tachycardia (stable/unstable), Acute Coronary Syndrome, Suspected Stroke.
• Pharmacology – indications, dosing, and contraindications of epinephrine, amiodarone, lidocaine, magnesium, adenosine, beta‑blockers, calcium channel blockers, anticoagulants, and thrombolytics.
• Electrophysiology – interpretation of ECG rhythms, identification of ischemic changes, and recognition of life‑threatening arrhythmias.
• Team dynamics and communication – roles of the team leader, closed‑loop communication, and prioritization of interventions.
• Post‑cardiac arrest care – targeted temperature management, hemodynamics, and neurologic prognostication.

Understanding how each of these topics interrelates is crucial because Exam A often combines elements from multiple areas within a single scenario.

Sample Questions and Detailed Answers

Below are representative questions that mirror the style and difficulty of Exam A. Each answer includes a brief rationale that highlights why the correct choice is best and why the distractors are incorrect.

1. Cardiac Arrest – Ventricular Fibrillation

Question: A 58‑year‑old man collapses suddenly. Bystanders initiate CPR and attach an AED, which advises a shock. After the first shock, the rhythm remains ventricular fibrillation. What is the next immediate action?

A. Resume chest compressions for 2 minutes, then check rhythm
B. Administer 1 mg epinephrine IV
C. Give 300 mg amiodarone IV push
D. Perform endotracheal intubation

Answer: A – Resume chest compressions for 2 minutes, then check rhythm

Rationale: After each defibrillation attempt, the AHA algorithm directs rescuers to immediately resume high‑quality CPR for 2 minutes (approximately 5 cycles) before reassessing the rhythm. Epinephrine is administered after the second shock if VF/pVT persists, and antiarrhythmics such as amiodarone are considered after the third shock. Intubation, while important, should not interrupt compressions; it can be performed during the CPR pause if needed.

2. Bradycardia Algorithm

Question: A 67‑year‑old woman presents with symptomatic bradycardia (heart rate 38 bpm), hypotension (BP 80/50 mm Hg), and mild shortness of breath. She has no signs of ischemia. According to the ACLS bradycardia algorithm, what is the first intervention?

A. Atropine 0.5 mg IV
B. Transcutaneous pacing
C. Epinephrine infusion 2–10 µg/min
D. Dopamine infusion 5–20 µg/kg/min

Answer: A – Atropine 0.5 mg IV

Rationale: For symptomatic bradycardia with adequate perfusion, the initial step is atropine 0.5 mg IV, repeatable every 3–5 minutes up to a total dose of 3 mg. If atropine fails or the patient exhibits signs of poor perfusion (e.g., severe hypotension, altered mental status), transcutaneous pacing is initiated. Vasopressor infusions are reserved for cases where pacing is not immediately available or ineffective.

3. Stable Wide‑Complex Tachycardia

Question: A 45‑year‑old man with a history of coronary artery disease presents with palpitations. His ECG shows a regular wide‑complex tachycardia at 150 bpm, blood pressure 128/78 mm Hg, and he is asymptomatic. What is the most appropriate initial treatment?

A. Adenosine 6 mg IV rapid push
B. Procainamide 20 mg/min infusion until arrhythmia terminates or hypotension develops
C. Synchronized cardioversion at 100 J
D. Amiodarone 150 mg IV over 10 minutes Answer: B – Procainamide infusion

Rationale: In a stable patient with monomorphic wide‑complex tachycardia (likely ventricular tachycardia), the first‑line pharmacologic therapy is a procainamide infusion. Adenosine is ineffective for ventricular tachycardia and may worsen the rhythm. Synchronized cardioversion is reserved for unstable patients. Amiodarone is an alternative but is generally considered after procainamide or if the patient has structural heart disease and procainamide is contraindicated.

4. Acute Coronary Syndrome – NSTEMI

Question: A 62‑year‑old woman experiences 30 minutes of substernal chest pressure radiating to her left arm. Her initial troponin is elevated, ECG shows 1 mm ST‑segment depression in leads V4–V6. She is hemodynamically stable. Which medication should be administered immediately?

A. Morphine 2–4 mg IV
B. Clopidogrel 300 mg PO
C. Heparin bolus 60 units/kg IV
D. Nitroglycerin sublingual 0.4 mg

Answer: C – Heparin bolus 60 units/kg IV

Rationale: For patients with NSTEMI, anticoagulation with unfractionated heparin (or low‑molecular‑weight heparin) is initiated promptly to prevent thrombus propagation. Antiplatelet therapy (aspirin plus a P2Y12 inhibitor such as clopidogrel) is also essential, but heparin is the immediate anticoagulant. Morphine is used for pain refractory to nitroglycerin, and nitroglycerin is given for ongoing ischemia unless contraindicated by hypotension or

4. Acute Coronary Syndrome – NSTEMI (Continuation of Rationale)

Answer: C – Heparin bolus 60 units/kg IV
Rationale: ...unless contraindicated by hypotension or recent use of a phosphodiesterase inhibitor (e.g., sildenafil). Antiplatelet therapy (aspirin and a P2Y12 inhibitor like clopidogrel) is initiated concurrently but is not the immediate priority over anticoagulation. Morphine is reserved for refractory pain, as it may cause hypotension and delay nitrate absorption.

5. Pulseless Electrical Activity (PEA) Arrest

Question: During a cardiac arrest code, the monitor shows organized electrical activity (50 bpm) but no palpable pulse. CPR is in progress, and advanced airway is secured. What is the next critical intervention?
A. Epinephrine 1 mg IV/IO
B. Immediate transcutaneous pacing
C. Search for reversible causes (H’s & T’s)
D. Amiodarone 300 mg IV/IO bolus

Answer: C – Search for reversible causes (H’s & T’s)
Rationale: PEA requires immediate identification and correction of reversible etiologies (e.g., hypovolemia, hypoxia, hydrogen ion [acidosis], hypokalemia/hyperkalemia, hypothermia, tension pneumothorax, toxins, tamponade, thrombosis). While epinephrine is administered during CPR (per ACLS guidelines), the priority in PEA is to diagnose and treat the underlying cause. Pacing is ineffective without mechanical capture, and antiarrhythmals are not first-line.

6. Asymptomatic Bradycardia in a Post-Op Patient

Question: A 70-year-old post-operative patient has a heart rate of 40 bpm with stable blood pressure (110/70 mmHg), oxygen saturation 95%, and no symptoms. ECG shows sinus bradycardia. What is the most appropriate management?
A. Atropine 0.5 mg IV
B. Transvenous pacing
C. Observation and monitoring
D. Dopamine infusion 5–10 µg/kg/min

Answer: C – Observation and monitoring
Rationale: Asymptomatic bradycade with adequate perfusion requires no intervention unless symptomatic or hemodynamically unstable. Atropine is reserved for symptomatic cases. Pacing or vasopressors are unnecessary if the patient is stable. Monitoring for worsening bradycardia or symptom development is sufficient.

Conclusion

These scenarios underscore the foundational principles of emergency cardiac care: stability assessment guides intervention, rhythm-specific protocols dictate treatment, and timely action is critical. From pharmacologic management of arrhythmias to rapid reversal of arrest causes, each decision hinges on recognizing clinical context, adhering to evidence-based guidelines (e.g., ACLS), and prioritizing reversible etiologies. Mastery of these algorithms ensures efficient, life-saving responses in high-stakes environments, emphasizing that systematic evaluation—not reflexive action—is the cornerstone of effective resuscitation.